This consensus document provides expert guidance on the clinical utility of natriuretic peptides, including BNP assays and nesiritide, in cardiovascular diseases.
No takes yet. Share an insight, caveat, or question.
Guides natriuretic peptide use in HF diagnosis and monitoring; extends evidence synthesis for guideline-directed care and trials.
Silver et al. (2004) conducted a review in Heart failure and cardiovascular diseases. Natriuretic peptides (BNP, nesiritide) was evaluated. An expert Consensus Panel summarized current knowledge on the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: